Mindfulness App Training for Heart Disease
(MATCH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how a mindfulness app can reduce stress in individuals at risk for heart disease. Participants will either use the app with guided meditation lessons (Mindfulness Training) or continue their usual care routine, receiving stress management resources (Enhanced Usual Care). The study will track stress levels using phone and sensor data to assess the app's effectiveness. Suitable candidates include those living in the Pittsburgh area with high stress, high blood pressure, and possibly diabetes or high cholesterol. As an unphased trial, this study provides a unique opportunity to explore innovative stress reduction methods that could enhance heart health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual care, as the study compares mindfulness training to regular routines.
What prior data suggests that this mindfulness training is safe for individuals at risk for cardiovascular disease?
Research shows that mindfulness training is generally safe for most people. Studies have found that mindfulness activities can help reduce stress and manage high blood pressure. For instance, one study showed that a mindfulness program effectively lowered stress levels in healthcare workers. Another study found that practicing mindfulness can help people feel more balanced and connected, which is important for overall well-being.
Participants in these studies did not report any major negative effects from mindfulness practices. This suggests that most people handle mindfulness training well. As always, individuals should consider their own health conditions and consult a healthcare provider before starting any new health program, but current evidence supports the safety of mindfulness training.12345Why are researchers excited about this trial?
Researchers are excited about the Mindfulness Training app because it offers a unique approach to managing heart disease by focusing on mental well-being through mindfulness. Unlike traditional treatments that often rely on medication or lifestyle changes, this app delivers 28 audio-guided lessons to teach meditation techniques like concentration, sensory clarity, and equanimity. The app also provides daily practice prompts to reinforce these skills. This method could provide a convenient, non-pharmacological tool to help individuals manage stress, which is a key factor in heart disease.
What evidence suggests that this mindfulness training might be an effective treatment for heart disease?
Research has shown that mindfulness training, which participants in this trial may receive, benefits heart health. A review of studies found that mindfulness-based activities help reduce anxiety and stress, both linked to heart disease. Another study found that these programs lower blood pressure and body mass index, both crucial for heart health. Guided meditations and mindfulness techniques have also been linked to better blood pressure control and improvements in heart health markers. These findings suggest that mindfulness training might help manage stress and improve overall heart health, which is vital for those at risk of heart disease.678910
Who Is on the Research Team?
Thomas W Kamarck, PhD
Principal Investigator
University of Pittsburgh
Emily K Lindsay, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
Adults aged 45+ in the Pittsburgh area with hypertension and moderate-to-high cardiovascular risk are eligible. They must have a compatible smartphone, speak English well, and be available for study visits. Excluded are those with severe heart conditions, night shift workers, heavy drinkers or drug users, pregnant women, individuals with certain mental health issues or who practice mind-body exercises regularly.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a smartphone-based mindfulness training program or continue their regular routines for 4 weeks
Post-Intervention Monitoring
Participants complete a second week of daily life monitoring, including assessments of stress reactivity and cardiovascular responses
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a third week of monitoring three months later
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Usual Care
- Mindfulness Training
Enhanced Usual Care is already approved in United States, European Union, China for the following indications:
- Hepatic encephalopathy
- Constipation
- Hepatic encephalopathy
- Constipation
- Hepatic encephalopathy
- Constipation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator